April 19, 2024
Market Now
Yuhan inks W65.4b deal with Gilead
[DISCLOSURE] Yuhan (000100) announced on Dec. 8 that it has signed a 65.4 billion won (US$59.89 million) contract with Island’s Gilead Sciences to supply active pharmaceutical ingredients for HIV treatments.
This amounts to 4.9 percent of its 2016 revenue and the contract is valid until Jan. 31, 2019.
By Hwang You-mee (glamazon@heraldcorp.com)
This amounts to 4.9 percent of its 2016 revenue and the contract is valid until Jan. 31, 2019.
By Hwang You-mee (glamazon@heraldcorp.com)
